List view / Grid view

UK Government



ESG considerations in Europe and Asia: social inclusion – the new diversity frontier in life sciences

1 July 2022 | By ,

With the focus on environmental, social and governance (ESG) issues rising worldwide, in this article, Morgan, Lewis & Bockius LLP Partners, Lesli Ligorner and Louise Skinner discuss the evolving landscape, presenting the emerging regulations for reporting social factors across Asia and Europe.


EU pharmaceutical regulatory outlook for 2022

22 February 2022 | By

How will a new regulatory landscape impact the EU and UK pharma industries? Early 2022 will see major new clinical trial legislation come into effect, with proposals for an entirely new regulatory regime promised by the end of the year. Paul Ranson, Consultant at Morgan Lewis, reflects on this and…